Join tombal & me in a fun virtual educational webinar! Link: us02web.zoom.us/webinar/regist… Mirrors of Medicine Marinos Tsiatas MikaLion ANASTASIOS KYRIAZOGLOU Ζenia Saridaki Daniele Raggi Laura Marandino Amalya Sargsyan Myrto K. Moutafi Evangelia (Elina) Vlachou, MD Bernadett Szabados Umang Swami Abhishek Tripathi OncoAlert

Proud to share that our collaborative review on Combination Therapies in Locally Advanced PC and mHSPC is now available in European Urology authors.elsevier.com/sd/article/S03…. Thanks to this wonderful team, especially to Arun Azad and Karim Fizazi. So honoured to be involved!

Very nice summary of the benefit of LHRH antagonists in patients with prostate cancer and significant LUTS Vérane Achard #EAU2025

How to optimize outcomes in men with biochemical recurrence after local treatment with curative intent. Presentation by tombal. #EAU25 written coverage by Julian Chavarriaga > bit.ly/4hBGcxV European Association of Urology (EAU)

👩‍🏫 If you are attending the EAU Congress 2025 in Madrid, do not miss Dr Fred Saad's oral presentation on the EORTC-GUCG 1333/PEACE-3 trial today at 13:45 CET. More info available here: scientific-programme.uroweb.org/EAU25/programme #EAU25 #CancerResearch #ClinicalTrials #Oncology #EORTCgenitourinary

Data from Peace3 presented by Fred Saad clearly suggest that early administration of bone protecting agent increase rPFS and OS in patients receiving enzalutamide +- Ra223 EORTC GETUG SOGUG LACOG - Latin American Cooperative Oncology Group silke gillessen #EAU2025

Fast (< 30 min) “All-in-One” whole-body MRI for TNM staging in high-risk prostate cancer (PCa), clearly an alternative Cliniques universitaires Saint-Luc Irene -IX ejradiology.com/article/S0720-…

On the eve of #ASCO25, I am delighted to share results from the correlative analyses of the ANZUP phase II TheraP study, now published in Nature Medicine. Massive effort supported by dedicated co-investigators, coordinators, patients & families from 11 study sites across

Sharpen your approach to mCRPC with the latest, most revolutionary trial data, and expert guidance via tombal Pedro C Barata, MD MSc FACP Alicia Morgans, MD, MPH on applying it to your practice. ICYMI at major meetings this year 💥 ms.spr.ly/6017Sd2rH

Patience and resilience are the bedrock of every academic triumph. But none of this would exist without the trust of our patients, the dedication of our nurses, and the relentless support of the EORTC HQ team. The spotlight belongs to you, not us. I love you all…EORTC

In PEACE-3 (EORTC 1333), the addition of 6 cycles of Ra223 to enzalutamide improves PSA response time and rates (≥90%), ALP reduction time (≥30%), and ALP normalization at 6 and 12 months. EORTC silke gillessen Andrey Soares GETUG CancerTrialsIreland 🌈 SOGUG

Are we ready for ARPI alone therapy in mCSPC? Is a non-inferiority trial needed? Great lecture by tombal at #UROonco25 in Sevilla but the debate is still open... European Association of Urology (EAU) European Urology OncoDaily OncoAlert UroFocus Alessandro Volpe Morgan Roupret

ARASENS trial update (darolutamide vs placebo in combination with docetaxel + androgen deprivation therapy in metastatic hormone sensitive #ProstateCancer ) ⬆️Postprogression OS favored ARPI over taxane after placebo+docetaxel+ADT, but OS remained inferior vs darolutamide arm.

Why attend #RENALC25, #BLADDR25 and #PROSCA25? Hear it straight from Vérane Achard in this quick video 👇 ➡️ Register now: tinyurl.com/mryx8kwe 💎Dive into the clinical application of new GU oncology data 👥 Learn from multidisciplinary experts 🗓️3-6 December 2025 | 📍

Honored to be co–first author with Huck constance on this paper challenging dogma. Next : #BRACEClinicalTrial, which I co-lead with Piet Dirix, opening soon in BE🇧🇪 thanks to #komOpTegenKanker and EORTC . We aim to explore the role of RT in BCG-unresponsive CIS. Stay tuned!

🇫🇷🇧🇪Ouverture des JER du GETUG avec le débat sur la prise en charge des mCRPC. ✨ Roubaud Guilhem tombal Helissey carole Bernard-Tessier

🌟Challenges in Defining Clinical CR to Systemic Therapy in MIBC🌟 EORTC #STARBURST project 🖋️ Alexandra Masson-Lecomte @AFUrology, Guillaume Grisay, Julien Van Damme,  Vérane Achard  , Laura S. Mertens, Robert Huddart💙, francesco soria, Lars Dyrskjøt, Yves Allory Institut Curie,

It's time to reconsider how we view patient involvement in developing clinical trials, beyond just asking them to review the ICF. Beautyfull work by Laureline Gatellier sciencedirect.com/science/articl…

Designing an academic clinical trial isn’t easy. It takes patience, devoted colleagues, and a great organization. Convergence of science, regulations and society in cancer clinical research sciencedirect.com/science/articl… EORTC

Systemic treatment for nonmuscle-invasive #BladderCancer: Clinical precision or overreaction? Presentation by Bradley McGregor Dana-Farber. #ESMO25 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/47fRBQQ ESMO - Eur. Oncology Ashish M. Kamat, MD, MBBS